FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2158885282> ?p ?o ?g. }

• W2158885282 endingPage "679" @default.
• W2158885282 startingPage "674" @default.
• W2158885282 abstract "To evaluate the therapeutic efficacy of bevacizumab and cetuximab, alone and in combination, in an orthotopic model of anaplastic thyroid carcinoma (ATC) in athymic nude mice.This was a randomized, controlled in vivo study.The ATC cell line, ARO, was used to establish orthotopic xenografts of ATC in athymic nude mice. Mice were randomized to therapy for 4 weeks in one of four treatment groups: placebo, cetuximab, bevacizumab, or the combination of cetuximab and bevacizumab. A second study compared the antitumor efficacy of the cetuximab-bevacizumab combination with doxorubicin. In both studies, tumor volumes on completion were measured and compared. Immunohistochemical analysis was performed with antiCD31 and antiproliferating cell nuclear antigen (PCNA) antibodies to assess the in vivo mechanisms of action of these agents.Cetuximab decreased the production of vascular endothelial growth factor by ATC cell lines in vitro. Mean tumor volumes for the control, bevacizumab, cetuximab, and combination groups at the end of the in vivo study were 291, 213, 94, and 42 mm(3), respectively. The differences in mean tumor volume for the control versus treatment groups were statistically significant. Immunohistochemical analysis showed decreased microvessel density and PCNA positivity in the treatment groups. In the doxorubicin comparison study, mean tumor volumes for control, doxorubicin, and combination antibody treatment groups were 175, 162, and 22 mm(3), respectively.Cetuximab and bevacizumab alone and in combination inhibit tumor growth and angiogenesis in an in vivo model of ATC. Also, this therapy was superior to doxorubicin therapy." @default.
• W2158885282 created "2016-06-24" @default.
• W2158885282 creator A5013654024 @default.
• W2158885282 creator A5016605564 @default.
• W2158885282 creator A5028189327 @default.
• W2158885282 creator A5044033105 @default.
• W2158885282 creator A5068753884 @default.
• W2158885282 creator A5068859775 @default.
• W2158885282 creator A5091911937 @default.
• W2158885282 date "2007-04-01" @default.
• W2158885282 modified "2023-09-27" @default.
• W2158885282 title "Concurrent Cetuximab and Bevacizumab Therapy in a Murine Orthotopic Model of Anaplastic Thyroid Carcinoma" @default.
• W2158885282 cites W1964115821 @default.
• W2158885282 cites W1969203269 @default.
• W2158885282 cites W2036926586 @default.
• W2158885282 cites W2063524499 @default.
• W2158885282 cites W2080267208 @default.
• W2158885282 cites W2098765174 @default.
• W2158885282 cites W2099855073 @default.
• W2158885282 cites W2117487833 @default.
• W2158885282 cites W2134084265 @default.
• W2158885282 cites W2144064311 @default.
• W2158885282 cites W2154048880 @default.
• W2158885282 cites W4240811981 @default.
• W2158885282 doi "https://doi.org/10.1097/mlg.0b013e318031055e" @default.
• W2158885282 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17429874" @default.
• W2158885282 hasPublicationYear "2007" @default.
• W2158885282 type Work @default.
• W2158885282 sameAs 2158885282 @default.
• W2158885282 citedByCount "45" @default.
• W2158885282 countsByYear W21588852822012 @default.
• W2158885282 countsByYear W21588852822013 @default.
• W2158885282 countsByYear W21588852822015 @default.
• W2158885282 countsByYear W21588852822016 @default.
• W2158885282 countsByYear W21588852822017 @default.
• W2158885282 countsByYear W21588852822018 @default.
• W2158885282 countsByYear W21588852822019 @default.
• W2158885282 countsByYear W21588852822020 @default.
• W2158885282 countsByYear W21588852822021 @default.
• W2158885282 countsByYear W21588852822022 @default.
• W2158885282 countsByYear W21588852822023 @default.
• W2158885282 crossrefType "journal-article" @default.
• W2158885282 hasAuthorship W2158885282A5013654024 @default.
• W2158885282 hasAuthorship W2158885282A5016605564 @default.
• W2158885282 hasAuthorship W2158885282A5028189327 @default.
• W2158885282 hasAuthorship W2158885282A5044033105 @default.
• W2158885282 hasAuthorship W2158885282A5068753884 @default.
• W2158885282 hasAuthorship W2158885282A5068859775 @default.
• W2158885282 hasAuthorship W2158885282A5091911937 @default.
• W2158885282 hasConcept C121608353 @default.
• W2158885282 hasConcept C126322002 @default.
• W2158885282 hasConcept C142724271 @default.
• W2158885282 hasConcept C143998085 @default.
• W2158885282 hasConcept C150903083 @default.
• W2158885282 hasConcept C204232928 @default.
• W2158885282 hasConcept C207001950 @default.
• W2158885282 hasConcept C2776694085 @default.
• W2158885282 hasConcept C2776999253 @default.
• W2158885282 hasConcept C2777802072 @default.
• W2158885282 hasConcept C2779761222 @default.
• W2158885282 hasConcept C2779998722 @default.
• W2158885282 hasConcept C2780256643 @default.
• W2158885282 hasConcept C2780394083 @default.
• W2158885282 hasConcept C2781303535 @default.
• W2158885282 hasConcept C502942594 @default.
• W2158885282 hasConcept C526805850 @default.
• W2158885282 hasConcept C71924100 @default.
• W2158885282 hasConcept C86803240 @default.
• W2158885282 hasConceptScore W2158885282C121608353 @default.
• W2158885282 hasConceptScore W2158885282C126322002 @default.
• W2158885282 hasConceptScore W2158885282C142724271 @default.
• W2158885282 hasConceptScore W2158885282C143998085 @default.
• W2158885282 hasConceptScore W2158885282C150903083 @default.
• W2158885282 hasConceptScore W2158885282C204232928 @default.
• W2158885282 hasConceptScore W2158885282C207001950 @default.
• W2158885282 hasConceptScore W2158885282C2776694085 @default.
• W2158885282 hasConceptScore W2158885282C2776999253 @default.
• W2158885282 hasConceptScore W2158885282C2777802072 @default.
• W2158885282 hasConceptScore W2158885282C2779761222 @default.
• W2158885282 hasConceptScore W2158885282C2779998722 @default.
• W2158885282 hasConceptScore W2158885282C2780256643 @default.
• W2158885282 hasConceptScore W2158885282C2780394083 @default.
• W2158885282 hasConceptScore W2158885282C2781303535 @default.
• W2158885282 hasConceptScore W2158885282C502942594 @default.
• W2158885282 hasConceptScore W2158885282C526805850 @default.
• W2158885282 hasConceptScore W2158885282C71924100 @default.
• W2158885282 hasConceptScore W2158885282C86803240 @default.
• W2158885282 hasIssue "4" @default.
• W2158885282 hasLocation W21588852821 @default.
• W2158885282 hasLocation W21588852822 @default.
• W2158885282 hasOpenAccess W2158885282 @default.
• W2158885282 hasPrimaryLocation W21588852821 @default.
• W2158885282 hasRelatedWork W1792988773 @default.
• W2158885282 hasRelatedWork W1963973664 @default.
• W2158885282 hasRelatedWork W1993235655 @default.
• W2158885282 hasRelatedWork W2066462266 @default.
• W2158885282 hasRelatedWork W2098707609 @default.
• W2158885282 hasRelatedWork W2563870823 @default.

• next